{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:44:24Z","timestamp":1785915864732,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005224","name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011736","name":"State Ministry of Baden-Wuerttemberg for Economic Affairs Labour and Housing Construction","doi-asserted-by":"publisher","award":["FKZ AZ 35-4223.10\/8"],"award-info":[{"award-number":["FKZ AZ 35-4223.10\/8"]}],"id":[{"id":"10.13039\/501100011736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.parkreldis.2026.108380","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:37:50Z","timestamp":1781023070000},"page":"108380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPAR\u03b3 levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageing"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5750-7274","authenticated-orcid":false,"given":"Madeleine","family":"Fandrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Jakobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Roeben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Wurster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5508-004X","authenticated-orcid":false,"given":"Stefanie","family":"Lerche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Deuschle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Schneiderhan-Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas O.","family":"Joos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1069-1146","authenticated-orcid":false,"given":"Thomas","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7066-7749","authenticated-orcid":false,"given":"Milan","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2026.108380_bib1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.52.6.1214","article-title":"Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990","volume":"52","author":"Bower","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2026.108380_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.365","article-title":"Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K\/AKT pathway during tacrolimus-induced oxidative stress","volume":"8","author":"Lim","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.parkreldis.2026.108380_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1083\/jcb.201008167","article-title":"Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome","volume":"192","author":"Morselli","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.parkreldis.2026.108380_bib4","first-page":"147","article-title":"Insulin, IGF-1 and longevity","volume":"1","author":"van Heemst","year":"2010","journal-title":"Aging Dis"},{"key":"10.1016\/j.parkreldis.2026.108380_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.febslet.2007.11.034","article-title":"Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways","volume":"582","author":"Rodgers","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.parkreldis.2026.108380_bib6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.parkreldis.2026.108380_bib7","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00018-011-0850-z","article-title":"Transgenic expression and activation of PGC-1alpha protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease","volume":"69","author":"Mudo","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.parkreldis.2026.108380_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2010.02.034","article-title":"Reduced expression of peroxisome-proliferator activated receptor gamma coactivator-1alpha enhances alpha-synuclein oligomerization and down regulates AKT\/GSK3beta signaling pathway in human neuronal cells that inducibly express alpha-synuclein","volume":"473","author":"Ebrahim","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2026.108380_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.583478","article-title":"Exercise-Induced autophagy suppresses Sarcopenia through Akt\/mTOR and Akt\/FoxO3a signal pathways and AMPK-mediated mitochondrial quality control","volume":"11","author":"Zeng","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.parkreldis.2026.108380_bib10","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.18632\/aging.102137","article-title":"Ginseng increases Klotho expression by FoxO3-mediated manganese superoxide dismutase in a mouse model of tacrolimus-induced renal injury","volume":"11","author":"Lim","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.parkreldis.2026.108380_bib11","doi-asserted-by":"crossref","first-page":"19201","DOI":"10.18632\/oncotarget.8450","article-title":"Curcumin elevates sirtuin level but does not postpone in vitro senescence of human cells building the vasculature","volume":"7","author":"Grabowska","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.parkreldis.2026.108380_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3934\/Neuroscience.2023005","article-title":"How can nanomicelle-curcumin modulate aluminum phosphide-induced neurotoxicity?: role of SIRT1\/FOXO3 signaling pathway","volume":"10","author":"Khodavysi","year":"2023","journal-title":"AIMS Neurosci"},{"key":"10.1016\/j.parkreldis.2026.108380_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.555409","article-title":"Natural compounds and autophagy: allies against neurodegeneration","volume":"8","author":"Stacchiotti","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.parkreldis.2026.108380_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.exger.2018.04.005","article-title":"Spermidine ameliorates the neuronal aging by improving the mitochondrial function in vitro","volume":"108","author":"Jing","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.parkreldis.2026.108380_bib15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1078223","article-title":"Extended longevity in mice lacking the insulin receptor in adipose tissue","volume":"299","author":"Bluher","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2026.108380_bib16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11064-014-1377-0","article-title":"PPARgamma and PGC-1alpha as therapeutic targets in Parkinson's","volume":"40","author":"Corona","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.parkreldis.2026.108380_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2350-12-69","article-title":"Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease","volume":"12","author":"Clark","year":"2011","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.parkreldis.2026.108380_bib18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/ene.13776","article-title":"Patient's perception: shorter and more severe prodromal phase in GBA-associated PD","volume":"26","author":"Zimmermann","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108380_bib19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/mds.27884","article-title":"Parkinson's Disease: glucocerebrosidase 1 mutation severity is associated with CSF Alpha-Synuclein profiles","volume":"35","author":"Lerche","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108380_bib20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/mds.27731","article-title":"Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile","volume":"34","author":"Lerche","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108380_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2026.108380_bib22","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108380_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2026.108380_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.parkreldis.2026.108380_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.parkreldis.2026.108380_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/jgs.14779","article-title":"Multicenter validation of an MMSE-MoCA conversion table","volume":"65","author":"Bergeron","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.parkreldis.2026.108380_bib27","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","article-title":"Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease","volume":"73","author":"Hoops","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2026.108380_bib28","series-title":"Manual for the Beck Depression Inventory-II","author":"Beck","year":"1996"},{"key":"10.1016\/j.parkreldis.2026.108380_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2017.05.009","article-title":"NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases","volume":"57","author":"Blauwendraat","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2026.108380_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.neurobiolaging.2007.08.019","article-title":"The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease","volume":"30","author":"Glodzik-Sobanska","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2026.108380_bib31","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/acn3.51676","article-title":"Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface","volume":"9","author":"Vermunt","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108380_bib32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00702-021-02351-x","article-title":"Cerebrospinal fluid alpha synuclein concentrations in patients with positive AD biomarkers and extrapyramidal symptoms","volume":"128","author":"Winkel","year":"2021","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.parkreldis.2026.108380_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.parkreldis.2021.08.004","article-title":"Biofluids profile of alpha-Klotho in patients with Parkinson's disease","volume":"90","author":"Sancesario","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2026.108380_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-021-00273-9","article-title":"Lewy body disease or diseases with lewy bodies?","volume":"8","author":"Mensikova","year":"2022","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.parkreldis.2026.108380_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101979","article-title":"Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease","volume":"89","author":"Nowell","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.parkreldis.2026.108380_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4172\/2324-8769.1000106","article-title":"Novel combinatorial therapeutic targeting of PAI-1 (SERPINE1) gene expression in Alzheimer's Disease","volume":"1","author":"Kutz","year":"2012","journal-title":"Mol Med Ther"},{"key":"10.1016\/j.parkreldis.2026.108380_bib37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbr.2014.08.014","article-title":"Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine","volume":"274","author":"Barbiero","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.parkreldis.2026.108380_bib38","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","article-title":"Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice","volume":"128","author":"Heneka","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2026.108380_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111058","article-title":"Treadmill exercise reduces alpha-synuclein spreading via PPARalpha","volume":"40","author":"Dutta","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.parkreldis.2026.108380_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41531-025-00978-1","article-title":"Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants","volume":"11","author":"Lerche","year":"2025","journal-title":"npj Parkinson's Dis."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026002075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026002075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:46:57Z","timestamp":1785912417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802026002075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"alternative-id":["S1353802026002075"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108380","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPAR\u03b3 levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageing","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108380"}}